The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation

被引:14
|
作者
Schoultz, Mariyana [1 ]
Atherton, Iain M. [1 ]
Hubbard, Gill [1 ]
Watson, Angus J. M. [1 ,2 ]
机构
[1] Univ Stirling, Sch Nursing Midwifery & Hlth, Ctr Hlth Sci, Inverness, Scotland
[2] Raigmore Hosp NHS Highland, Inverness, Scotland
关键词
Mindfulness-based cognitive therapy; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Quality of life; Pilot randomised controlled trial; ATTENTION AWARENESS SCALE; EDUCATION-PROGRAM; ACTIVITY INDEX; ANTIDEPRESSANTS; IMPACT; INTERVENTIONS; PREVALENCE; VALIDATION; DEPRESSION; MANAGEMENT;
D O I
10.1186/1745-6215-14-431
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Inflammatory bowel disease (IBD) is a chronic condition with an unpredictable disease course. Rates of anxiety and depression among IBD patients in relapse (active disease symptoms) as well as in remission are higher than in the general population. Previous studies suggest that the prolonged effect of pain, anxiety, distress and depression have a detrimental effect on patients'quality of life (QoL). Poor QoL in itself is associated with further symptom relapse. Mindfulness based cognitive therapy (MBCT) is a psychological group intervention that has the potential to improve QoL. When used in other chronic conditions, it demonstrated reduced negative effect from pain and psychological factors at completion of an 8-week MBCT course. The effect of MBCT has never been researched in IBD. The aim of this study is to obtain the information required to design a full scale randomised controlled trial (RCT) that will examine the effectiveness of MBCT in improving quality of life for IBD patients. Methods/Design: This is an exploratory RCT with embedded process evaluation. Forty IBD patients will be recruited from NHS outpatient gastroenterology clinics and will be randomised to either a MBCT (intervention) group or to a wait-list (control) group. All participants will undergo 16 h of structured group training over an 8-week period, with the control group starting 6 months later than the intervention group. Primary outcomes are recruitment, completion/retention rates and adherence and adaptation to the MBCT manual for IBD patients. The secondary outcome is to assess the feasibility of collecting reliable and valid data on proposed outcome measures such as quality of life, anxiety, depression, disease activity and mindful awareness. The process evaluation will use a survey and focus groups to assess the acceptability of the intervention and trial procedures for IBD patients. Discussion: The outcomes of this study will help define the barriers, uptake and perceived benefits of MBCT program for IBD patients. This information will enable the design of a full-scale study assessing the effect of MBCT on quality of life for IBD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] The use of mindfulness-based cognitive therapy for improving quality of life for inflammatory bowel disease patients: study protocol for a pilot randomised controlled trial with embedded process evaluation
    Mariyana Schoultz
    Iain M Atherton
    Gill Hubbard
    Angus JM Watson
    Trials, 14
  • [2] Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial
    Schoultz, Mariyana
    Atherton, Iain
    Watson, Angus
    TRIALS, 2015, 16
  • [3] Mindfulness-based cognitive therapy for inflammatory bowel disease patients: findings from an exploratory pilot randomised controlled trial
    Mariyana Schoultz
    Iain Atherton
    Angus Watson
    Trials, 16
  • [4] Effectiveness of Mindfulness-Based Cognitive Therapy in reducing psychological distress and improving sleep in patients with Inflammatory Bowel Disease: study protocol for a multicentre randomised controlled trial (MindIBD).
    ter Avest, Milou M.
    van Velthoven, Annelieke S. M.
    Speckens, Anne E. M.
    Dijkstra, Gerard
    Dresler, Martin
    Horjus, Carmen S.
    Romkens, Tessa E. H.
    Witteman, Ellen M.
    van Dop, Willemijn A.
    Bredero, Quirine M.
    Nissen, Loes H. C.
    Huijbers, Marloes J.
    BMC PSYCHOLOGY, 2023, 11 (01)
  • [5] Effectiveness of Mindfulness-Based Cognitive Therapy in reducing psychological distress and improving sleep in patients with Inflammatory Bowel Disease: study protocol for a multicentre randomised controlled trial (MindIBD).
    Milou M ter Avest
    Annelieke S M van Velthoven
    Anne E M Speckens
    Gerard Dijkstra
    Martin Dresler
    Carmen S Horjus
    Tessa E H Römkens
    Ellen M Witteman
    Willemijn A van Dop
    Quirine M Bredero
    Loes H C Nissen
    Marloes J Huijbers
    BMC Psychology, 11
  • [6] Mindfulness-Based Cognitive Therapy for Fatigue in Patients with Inflammatory Bowel Disease: Results of a Randomized Controlled Trial
    Bredero, Quirine M.
    Fleer, Joke
    Smink, Ans
    Kuiken, Greetje
    Potjewijd, Joke
    Laroy, Marleen
    Visschedijk, Marijn C.
    Russel, Maurice
    van der Lugt, Mark
    Meijssen, Maarten A. C.
    van der Wouden, Egbert Jan
    Dijkstra, Gerard
    Schroevers, Maya J.
    MINDFULNESS, 2023, 14 (01) : 19 - 32
  • [7] Cognitive-behavioural therapy has no effect on disease activity but improves quality of life in subgroups of patients with inflammatory bowel disease: a pilot randomised controlled trial
    Mikocka-Walus, Antonina
    Bampton, Peter
    Hetzel, David
    Hughes, Patrick
    Esterman, Adrian
    Andrews, Jane M.
    BMC GASTROENTEROLOGY, 2015, 15
  • [8] Participants' perspectives on mindfulness-based cognitive therapy for inflammatory bowel disease: A qualitative study nested within a pilot randomised controlled trial
    Schoultz M.
    Macaden L.
    Hubbard G.
    Pilot and Feasibility Studies, 2 (1)
  • [9] Mindfulness-Based Cognitive Therapy for Fatigue in Patients with Inflammatory Bowel Disease: Results of a Randomized Controlled Trial
    Quirine M. Bredero
    Joke Fleer
    Ans Smink
    Greetje Kuiken
    Joke Potjewijd
    Marleen Laroy
    Marijn C. Visschedijk
    Maurice Russel
    Mark van der Lugt
    Maarten A.C. Meijssen
    Egbert Jan van der Wouden
    Gerard Dijkstra
    Maya J. Schroevers
    Mindfulness, 2023, 14 : 19 - 32
  • [10] The effect of a mindfulness-based therapy on different biomarkers among patients with inflammatory bowel disease: a randomised controlled trial
    Gonzalez-Moret, Rafael
    Cebolla, Ausias
    Cortes, Xavier
    Banos, Rosa M.
    Navarrete, Jaime
    de la Rubia, Jose Enrique
    Lison, Juan Francisco
    Soria, Jose Miguel
    SCIENTIFIC REPORTS, 2020, 10 (01)